Donor Government Funding for Global Family Planning Declines to Lowest Level Since 2016
KFF | Healthcare Policy Issues
by
20h ago
A new KFF analysis finds donor government funding for family planning efforts in low- and middle-income countries totaled US$1.35 billion in 2022, a decline of 9% (US$129 million) compared to 2021 ($1.48 billion). This figure marks the lowest level of funding since 2016 ($1.31 billion). While some of the decline was because of decreases in…More ..read more
Visit website
An Estimated 1 in 4 Medicare Beneficiaries With Obesity or Overweight Could Be Eligible for Medicare Coverage of Wegovy, an Anti-Obesity Drug, to Reduce Heart Risk
KFF | Healthcare Policy Issues
by
20h ago
In a new analysis, KFF finds that 3.6 million people with Medicare could be eligible for coverage of Wegovy (semaglutide) now that the Food and Drug Administration has approved the use of the anti-obesity drug to reduce the risk of heart attacks and stroke in certain patients. This change potentially allows access to Wegovy for…More ..read more
Visit website
What are the Implications of the Dobbs Ruling for Racial Disparities?
KFF | Healthcare Policy Issues
by
20h ago
This analysis examines the implications of the Dobbs decision and state restrictions on abortion coverage for racial disparities in access to care and health outcomes ..read more
Visit website
Donor Government Funding for Family Planning in 2022
KFF | Healthcare Policy Issues
by
20h ago
This report provides an analysis of donor government funding to address family planning in low- and middle-income countries in 2022, which totaled US$1.35 billion and was a decline of 9% (US$129 million) compared to the 2021 amount (US$1.48 billion). While the decline was due to decreases in funding by most donor governments, a significant share can be attributed to exchange rate fluctuations resulting from the rise in value of the U.S. dollar against most currencies during 2022 ..read more
Visit website
A New Use for Wegovy Opens the Door to Medicare Coverage for Millions of People with Obesity
KFF | Healthcare Policy Issues
by
20h ago
The FDA recently approved a new use for Wegovy, the blockbuster anti-obesity drug, to reduce the risk of heart attacks and stroke in people with cardiovascular disease who are overweight or obese - a decision that opens the door to Medicare coverage of Wegovy, which is prohibited by law from covering drugs used for obesity. This brief analyses how many Medicare beneficiaries could be eligible for the new use of Wegovy and the potential impact on Medicare spending ..read more
Visit website
Examining New Medicaid Resources to Expand School-Based Behavioral Health Services
KFF | Healthcare Policy Issues
by
2d ago
In light of worsening mental health among youth, strategies have been implemented to improve access to behavioral health services in recent years, including expanding school-based care for students. Leveraging Medicaid to improve and address gaps in school-based behavioral health services has been a key strategy in recent years as youth mental health concerns have grown. Provisions from the Safer Communities Act of 2022 utilize Medicaid to expand both school-based health care and other mechanisms of youth behavioral health care. This issue brief explores the implementation of these provisions ..read more
Visit website
The Vast Majority of Nursing Facilities Will Need to Hire More Staff to Comply with the Final Federal Rule When Fully Implemented, Unless They Qualify for an Exemption
KFF | Healthcare Policy Issues
by
2d ago
Based on a new KFF analysis, fewer than 1 in 5 (19%) nursing facilities currently meet the minimum staffing standards set out in the final requirements of the federal rule released today by the Centers for Medicare and Medicaid Services (CMS). CMS adopted staffing standards that are similar to the staffing requirements in the rule…More ..read more
Visit website
With Current Staffing Levels, About 1 in 5 Nursing Facilities Would Meet Fully-Implemented Minimum Staffing Standards in the Final Rule
KFF | Healthcare Policy Issues
by
2d ago
This analysis uses the most recently-available data to examine the percentage of nursing facilities that currently meet the minimum staffing requirements in the final rule ..read more
Visit website
At the Supreme Court: What’s at Stake for Emergency Abortion Care?
KFF | Healthcare Policy Issues
by
3d ago
On April 24, the Supreme Court will hear Idaho v. United States—the second case this term involving access to abortion. In a new brief, KFF examines what’s at stake, focusing on whether the Emergency Medical Treatment and Active Labor Act (EMTALA)—a federal law requiring nearly all hospitals to ensure emergency room patients are stable before…More ..read more
Visit website
Abortion Back at SCOTUS: Can States Ban Emergency Abortion Care for Pregnant Patients?
KFF | Healthcare Policy Issues
by
3d ago
On April 24, 2024, the Supreme Court will hear the second case this term involving access to abortion: Idaho v. United States. At stake in this case is whether the Emergency Medical Treatment and Active Labor Act, a federal law requiring hospitals to provide stabilizing treatment to patients who present to their emergency rooms, preempts state abortion laws and requires hospitals that accept Medicare to provide abortion care when it is necessary to stabilize a patient’s condition, even when this abortion care violates state law ..read more
Visit website

Follow KFF | Healthcare Policy Issues on FeedSpot

Continue with Google
Continue with Apple
OR